Live feed
Filing
SC 13G
SC 13G0001144204-18-051200·Dexcel Pharma Technologies Ltd.
Schedule 13G ownership disclosure
Intec Pharma Ltd.
Security class unavailable · CUSIP: M53644106
Event date: 2018-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,788,400
- Percent of class
- 11.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-051200
- Form type
- SC 13G
- Filer
- Dexcel Pharma Technologies Ltd.
- CIK
- CIK 1720007
- Filed
- Sep 27, 2018
- Reporting period
- Sep 18, 2018
- Description
- Schedule 13G beneficial ownership